Unique ID issued by UMIN | UMIN000047150 |
---|---|
Receipt number | R000053786 |
Scientific Title | A Randomized Controlled Trial to Evaluate the Efficacy of plant-protein diets in Patients with Chronic Kidney Disease: a pilot-study |
Date of disclosure of the study information | 2022/03/11 |
Last modified on | 2023/09/11 12:34:20 |
A Randomized Controlled Trial to Evaluate the Efficacy of plant-protein diets in Patients with Chronic Kidney Disease: a pilot-study
A Randomized Controlled Trial to Evaluate the Efficacy of plant-protein diets in Patients with Chronic Kidney Disease: a pilot-study
A Randomized Controlled Trial to Evaluate the Efficacy of plant-protein diets in Patients with Chronic Kidney Disease: a pilot-study
A Randomized Controlled Trial to Evaluate the Efficacy of plant-protein diets in Patients with Chronic Kidney Disease: a pilot-study
Japan |
chronic kidney disease
Nephrology |
Others
NO
The purpose of this study is to evaluate the efficacy of plant-protein diets for 4 weeks in patients with advanced chronic kidney disease.
Efficacy
Change in serum levels of indoxyl sulfate, p-Cresyl sulfate and trimethylamine N-Oxide
1) Change in eGFR and urinary protein creatinine ratio
2) Change in serum bicarbonate levels
3) Change in systolic and diastolic blood pressure
4) Change in serum levels of calcium, phosphate, intact parathyroid hormone and intact fibroblast growth factor 23
5) Change in serum levels of acetic acid, propionic acid and butyric acid
6) Change in gut microbiome composition
7) Change in muscle strength
8) Dietary adherence
9) Oral medications including antihypertensive drugs, diuretics, potassium tablets, potassium binders, phosphate binders, calcium tablets, active vitamin D3 analogs and sodium bicarbonate
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Placebo
2
Treatment
Food |
plant-protein diets
control diets
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients with chronic kidney disease who were referred to the Outpatient Department of Nephrology at Osaka University Hospital
2) eGFR < 20 mL/min/1.73 m2
3) Taking anigiotensin-converting enzyme inhibitors or angiotensin II receptor blockers or angiotensin receptor neprilysin inhibitor
4) K < 5.5 mEq/L
1) Being planned to intitate renal replacement therapies within 3 months
2) Having inflammatory bowel diseases
3) History of gastrointestinal tract surgery
4) Taking antibiotics within 1 month before the entry
5) Taking or being planned to start warfarin
6) Having dietary allergies
7) Having difficulty in oral intake
8) During pregnancy or breastfeeding
9) Unsuitable for participant in the trial by an attending physician
40
1st name | Yusuke |
Middle name | |
Last name | Sakaguchi |
Osaka University Graduate School of Medicine
Department of Inter-Organ Communication Research in Kidney Diseases
565-0871
2-2, Yamadaoka, Suita, Osaka, Japan
06-6879-3747
sakaguchi@kid.med.osaka-u.ac.jp
1st name | Yusuke |
Middle name | |
Last name | Sakaguchi |
Osaka University Graduate School of Medicine
Department of Inter-Organ Communication Research in Kidney Diseases
565-0871
2-2, Yamadaoka, Suita, Osaka, Japan
06-6879-3747
sakaguchi@kid.med.osaka-u.ac.jp
Osaka University
None
Other
Osaka University Clinical Research Review Committee
2-2, Yamadaoka, Suita, Osaka, Japan
06-6210-8296
rinri@hp-crc.med.osaka-u.ac.jp
NO
2022 | Year | 03 | Month | 11 | Day |
Unpublished
40
No longer recruiting
2021 | Year | 11 | Month | 30 | Day |
2022 | Year | 03 | Month | 28 | Day |
2022 | Year | 04 | Month | 01 | Day |
2024 | Year | 03 | Month | 31 | Day |
2022 | Year | 03 | Month | 11 | Day |
2023 | Year | 09 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053786